China Botanic Pharmaceutical (CBP) Reports Q3 Earnings of $0.07; Affirms Outlook
Get Alerts CBP Hot Sheet
Join SI Premium – FREE
China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.07, versus $0.04 reported last year. Revenue for the quarter came in at $12.4 million, versus $9.3 million reported last year.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!